2021
DOI: 10.1002/jia2.25836
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020

Abstract: IntroductionMolecular surveillance systems could provide public health benefits to focus strategies to improve the HIV care continuum. Here, we infer the HIV genetic network of Mexico City in 2020, and identify actively growing clusters that could represent relevant targets for intervention.MethodsAll new diagnoses, referrals from other institutions, as well as persons returning to care, enrolling at the largest HIV clinic in Mexico City were invited to participate in the study. The network was inferred from H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 32 publications
1
10
0
Order By: Relevance
“…Unexpectedly, the odds of having PDR were not specifically higher in cisgender women, as observed in previous studies in Mexico and in other countries [5,9]. In the context of Mexico City, contrasted with other regions of Mexico, the epidemic is highly concentrated in MSM [15] who are generally younger, have a higher education level, and arrive earlier to clinical care than the heterosexual population [16,17]. In this context, MSM had significantly higher odds of efavirenz/nevirapine PDR compared to heterosexual cisgender men, possibly reflecting ongoing transmission of NNRTI resistance mutations such as K103NS and E138A.…”
Section: Discussionsupporting
confidence: 49%
See 2 more Smart Citations
“…Unexpectedly, the odds of having PDR were not specifically higher in cisgender women, as observed in previous studies in Mexico and in other countries [5,9]. In the context of Mexico City, contrasted with other regions of Mexico, the epidemic is highly concentrated in MSM [15] who are generally younger, have a higher education level, and arrive earlier to clinical care than the heterosexual population [16,17]. In this context, MSM had significantly higher odds of efavirenz/nevirapine PDR compared to heterosexual cisgender men, possibly reflecting ongoing transmission of NNRTI resistance mutations such as K103NS and E138A.…”
Section: Discussionsupporting
confidence: 49%
“…Sequences were obtained by next generation sequencing from a single amplicon including the complete protease (PR), reverse transcriptase (RT) and integrase (IN) genes (HXB2: PR 1-99, RT 1-560 and IN 1-288), using an in-house-validated method with Illumina sequencing technology on a MiSeq instrument (San Diego, CA, USA), as previously described [16,17]. A minority of the specimens in which amplification of this longer amplicon was not successful, as well as clinically indicated HIV genotypes for the ADR analysis, were amplified using a validated protocol developed by the US Centers for Disease Control and Prevention for the PR-RT region (HXB2 positions: PR 6-99, RT 1-251) [18] and an in-house developed and validated protocol for IN (HXB2: IN 1-288) [19].…”
Section: Hiv Amplification and Sequencingmentioning
confidence: 99%
See 1 more Smart Citation
“…The sequences were submitted to the Stanford University HIV Resistance Database (http://hivdb.stanford.edu/) to describe and interpret HIV-1 TDR. TDR level was classi ed according to the Stanford Penalty Score as high (60), intermediate , or low (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29) to the following drugs: PI, Protease inhibitor; NRTI, Nucleoside reverse transcriptase inhibitor; NNRTI, Non-nucleoside reverse transcriptase inhibitor; NFV: Nel navir; ABC: Abacavir; AZT: Zidovudine; D4T: Stavudine; DDI: Didanosine; FTC: Emtricitabine; 3TC, Lamivudine; TDF: Tenofovir; DOR: Doravirine; EFV: Efavirenz; ETR: Etravirine; RPV: Rilpivirine. Drug resistance mutations were analyzed using the CRP tool (http://cpr.stanford.edu/cpr.cgi).…”
Section: Drug Resistance Analysismentioning
confidence: 99%
“…Genetic transmission network, which constructed based on the genetic information of people infected with HIV through gene distance between sequences, widely used in the study of early HIV cases detection, long-term monitoring of drug resistance and targeted precision intervention [14][15][16][17][18]. Real-time genetic transmission network have been improved and further combined with social transmission network to judge new transmission events, identify high-risk spreaders and potential infected individuals and evaluate the effect of intervention measures [19][20][21]. Clustering analyses based on HIV drug resistance surveillance would rapidly detect and respond to emerging clusters of HIV infection to further reduce new transmissions, which is one pillar of the ending the HIV Epidemic plan in the United States [22].…”
Section: Introductionmentioning
confidence: 99%